Sellas Life Sciences Group, Inc. · NASDAQ:SLS
Highbridge Capital Management LLC's stake in Sellas Life Sciences Group, Inc. fell to 3.70% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
Highbridge Capital Management LLC's stake in Sellas Life Sciences Group, Inc. fell to 3.70%, 6,514,658 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 3.70%
- Shares
- 6,514,658
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Highbridge Capital Management, LLC | 3.70% | 6,514,658 |
Source
Related
- Sellas Life Sciences Group, Inc.
- Highbridge Capital Management LLC
- Sellas Life Sciences Group, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Stergiou Angelos M. · Jun 18, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 24, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026